DJIA 18,096.90 -106.47 -0.58%
NASDAQ 4,967.14 -12.76 -0.26%
S&P 500 2,098.53 -9.25 -0.44%
market minute promo


company name or ticker
Company Photos
(Click to zoom)

Sector Update: Health Stocks Higher Pre-Bell

Sector Update: Health Care

ARIAD Pharmaceuticals (ARIA) Showing Signs Of Perilous Reversal Today

ARIAD's Iclusig Gains Positive Recommendation from PRAC - Analyst Blog

Amgen's Blinatumomab Gets Priority Review in the U.S. - Analyst Blog

ARIAD Announces Recommendation For Iclusig By The Pharmacovigilance Risk Assessment Committee Of The

ARIAD Announces Recommendation For Iclusig By The Pharmacovigilance Risk Assessment Committee Of The European Medicines Agency

ARIAD Gets Breakthrough Therapy Designation for AP26113 - Analyst Blog

ARIAD Pharmaceuticals' All-In Bet On Europe

5 Stocks Under $10 Making Big Moves Higher

Why Ariad Pharmaceuticals, Inc. Stock Catapulted Higher

Ariad Pharmaceuticals stock is among today's top gainers after the Food and Drug Administration divvies a prized designation one of Ariad's pipeline products.